Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Xpediator plc - Danor Ionescu

6 Jan 2023 11:06

RNS Number : 9558L
Xpediator PLC
06 January 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Danor Ionescu

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xpediator plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

04.01.2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,163,106

2.93

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

4,163,106

2.93

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06.01.2023

Contact name:

Danor Ionescu

Telephone number*:

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSSSFSMEDSEDF
Date   Source Headline
14th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:00 pmRNSNotice of Results
17th Jul 20207:00 amRNSTrading Update
2nd Jul 202012:28 pmRNSDirector/PDMR Shareholding - Scrip Dividend
19th Jun 20203:30 pmRNSScrip Dividend Reference Price
5th Jun 20207:00 amRNSDirectorate Change
26th May 20203:45 pmRNSResult of AGM
26th May 20207:00 amRNSAGM Statement
21st May 20202:00 pmRNSScrip Dividend
4th May 20202:45 pmRNSNotice of AGM
20th Apr 20207:00 amRNSFinal Results
31st Mar 20207:00 amRNSCOVID-19 Update
4th Mar 20207:00 amRNSNew Warehouse Extension in Southampton Port
18th Feb 20207:00 amRNSDirectorate Update
10th Feb 20207:00 amRNSTrading Statement
5th Dec 201910:30 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSIssue of Equity
29th Nov 201911:30 amRNSDirector/PDMR Shareholding
27th Nov 201910:50 amRNSDirector/PDMR Shareholding
25th Nov 20192:30 pmRNSDirector/PDMR Shareholding
21st Nov 20193:45 pmRNSDirector/PDMR Shareholding
14th Nov 201910:15 amRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSDirectorate Change
4th Nov 20197:00 amRNSDirectorate Change
26th Sep 20197:00 amRNSHalf-year Report
6th Sep 20197:00 amRNSDirectorate Change
7th Aug 20197:00 amRNSChange of Adviser
30th Jul 20192:05 pmRNSSecond Price Monitoring Extn
30th Jul 20192:00 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSTrading Statement
25th Jun 20197:00 amRNSIssue of Equity
6th Jun 20194:50 pmRNSResult of AGM
6th Jun 20197:00 amRNSBoard Changes and Trading Update
4th Jun 201911:00 amRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSTotal Voting Rights
16th May 201910:00 amRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSIssue of Equity
10th May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSFinal Results
26th Apr 20199:30 amRNSUpdate on Intereuropa and Notice of Results
4th Mar 20197:00 amRNSSenior Management Appointment
18th Feb 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSSenior Management Appointment
16th Jan 20194:43 pmRNSStatement re Press Comment
27th Dec 201811:52 amRNSIssue of Equity
4th Dec 201811:05 amRNSSecond Price Monitoring Extn
4th Dec 201811:00 amRNSPrice Monitoring Extension
27th Nov 20187:00 amRNSDirector/PDMR Shareholding
23rd Nov 201811:30 amRNSXpediator to present at Mello London

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.